Literature DB >> 17688928

Psilocybin-induced stimulus control in the rat.

J C Winter1, K C Rice, D J Amorosi, R A Rabin.   

Abstract

Although psilocybin has been trained in the rat as a discriminative stimulus, little is known of the pharmacological receptors essential for stimulus control. In the present investigation rats were trained with psilocybin and tests were then conducted employing a series of other hallucinogens and presumed antagonists. An intermediate degree of antagonism of psilocybin was observed following treatment with the 5-HT(2A) receptor antagonist, M100907. In contrast, no significant antagonism was observed following treatment with the 5-HT(1A/7) receptor antagonist, WAY-100635, or the DA D(2) antagonist, remoxipride. Psilocybin generalized fully to DOM, LSD, psilocin, and, in the presence of WAY-100635, DMT while partial generalization was seen to 2C-T-7 and mescaline. LSD and MDMA partially generalized to psilocybin and these effects were completely blocked by M-100907; no generalization of PCP to psilocybin was seen. The present data suggest that psilocybin induces a compound stimulus in which activity at the 5-HT(2A) receptor plays a prominent but incomplete role. In addition, psilocybin differs from closely related hallucinogens such as 5-MeO-DMT in that agonism at 5-HT(1A) receptors appears to play no role in psilocybin-induced stimulus control.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17688928      PMCID: PMC2000343          DOI: 10.1016/j.pbb.2007.06.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  52 in total

1.  Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors:  M D Schechter
Journal:  Pharmacol Biochem Behav       Date:  1988-12       Impact factor: 3.533

2.  Marihuana and temporal disintegration.

Authors:  F T Melges; J R Tinklenberg; L E Hollister; H K Gillespie
Journal:  Science       Date:  1970-05-29       Impact factor: 47.728

3.  Xylamidine tosylate: differential antagonism of the hypothermic effects of N,N-dimethyltryptamine, bufotenine, and 5-methoxytryptamine.

Authors:  J C Winter
Journal:  Arch Int Pharmacodyn Ther       Date:  1972

4.  Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.

Authors:  S Helsley; D Fiorella; R A Rabin; J C Winter
Journal:  Pharmacol Biochem Behav       Date:  1998-02       Impact factor: 3.533

5.  Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

Authors:  E Gouzoulis-Mayfrank; B Thelen; E Habermeyer; H J Kunert; K A Kovar; H Lindenblatt; L Hermle; M Spitzer; H Sass
Journal:  Psychopharmacology (Berl)       Date:  1999-02       Impact factor: 4.530

6.  The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Authors:  C J Reissig; J R Eckler; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

7.  Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.

Authors:  J B Appel; P M Callahan
Journal:  Eur J Pharmacol       Date:  1989-01-02       Impact factor: 4.432

8.  Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.

Authors:  N Mohell; M Sällemark; S Rosqvist; A Malmberg; T Högberg; D M Jackson
Journal:  Eur J Pharmacol       Date:  1993-07-06       Impact factor: 4.432

9.  Serotonin receptor subtype mediation of the interoceptive discriminative stimuli induced by 5-methoxy-N,N-dimethyltryptamine.

Authors:  D G Spencer; T Glaser; J Traber
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

10.  The discriminative stimulus properties of 2,5-dimethoxy-4-methylamphetamine (DOM): differentiation from amphetamine.

Authors:  P B Silverman; B T Ho
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  22 in total

1.  Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice.

Authors:  J C Winter; D J Amorosi; Kenner C Rice; Kejun Cheng; Ai-Ming Yu
Journal:  Pharmacol Biochem Behav       Date:  2011-05-23       Impact factor: 3.533

Review 2.  The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

Authors:  Matthew W Johnson; Roland R Griffiths; Peter S Hendricks; Jack E Henningfield
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

3.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

4.  Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

Authors:  Clinton E Canal
Journal:  Handb Exp Pharmacol       Date:  2018

5.  Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression.

Authors:  Lindsay P Cameron; Charlie J Benson; Lee E Dunlap; David E Olson
Journal:  ACS Chem Neurosci       Date:  2018-04-24       Impact factor: 4.418

Review 6.  Potential Therapeutic Effects of Psilocybin.

Authors:  Matthew W Johnson; Roland R Griffiths
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

Review 7.  Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2011-01-20       Impact factor: 5.250

8.  Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.

Authors:  Adam L Halberstadt; Liselore Koedood; Susan B Powell; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2010-12-08       Impact factor: 4.153

9.  Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.

Authors:  Michael B Gatch; Margaret A Rutledge; Theresa Carbonaro; Michael J Forster
Journal:  Psychopharmacology (Berl)       Date:  2009-03-14       Impact factor: 4.530

Review 10.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.